- Home
- TCRX vs CEE Comparison
TCRX vs CEE Comparison
Compare TCRX & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- CEE
- Stock Information
- Founded
- TCRX 2018
- CEE 1990
- Country
- TCRX United States
- CEE Germany
- Employees
- TCRX N/A
- CEE N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- TCRX Health Care
- CEE Finance
- Exchange
- TCRX Nasdaq
- CEE Nasdaq
- Market Cap
- TCRX 100.7M
- CEE 97.8M
- IPO Year
- TCRX 2021
- CEE N/A
- Fundamental
- Price
- TCRX $1.44
- CEE $15.29
- Analyst Decision
- TCRX Strong Buy
- CEE
- Analyst Count
- TCRX 6
- CEE 0
- Target Price
- TCRX $9.50
- CEE N/A
- AVG Volume (30 Days)
- TCRX 470.2K
- CEE 22.0K
- Earning Date
- TCRX 08-11-2025
- CEE 01-01-0001
- Dividend Yield
- TCRX N/A
- CEE 3.86%
- EPS Growth
- TCRX N/A
- CEE N/A
- EPS
- TCRX N/A
- CEE N/A
- Revenue
- TCRX $4,421,000.00
- CEE N/A
- Revenue This Year
- TCRX $159.20
- CEE N/A
- Revenue Next Year
- TCRX N/A
- CEE N/A
- P/E Ratio
- TCRX N/A
- CEE N/A
- Revenue Growth
- TCRX N/A
- CEE N/A
- 52 Week Low
- TCRX $1.02
- CEE $7.80
- 52 Week High
- TCRX $7.89
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- TCRX 44.26
- CEE 46.93
- Support Level
- TCRX $1.44
- CEE $14.97
- Resistance Level
- TCRX $1.61
- CEE $15.49
- Average True Range (ATR)
- TCRX 0.16
- CEE 0.32
- MACD
- TCRX -0.02
- CEE -0.07
- Stochastic Oscillator
- TCRX 10.44
- CEE 37.31
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.